Literature DB >> 6706927

Biosynthesis of dermatan sulfate. II. Substrate specificity of the C-5 uronosyl epimerase.

A Malmström.   

Abstract

Epimerization of D-glucuronosyl residues to L-iduronosyl ones during biosynthesis of dermatan sulfate involves an abstraction of the C-5 hydrogen of the target sugar residue. After inversion, a hydrogen from the medium is reinserted into the uronosyl residue. In the present study, microsomal enzyme prepared from cultured embryonic skin fibroblasts was incubated with dermatan or chondroitin in the presence of 3H2O of high specific activity. Incubation resulted in incorporation of tritium on C-5 of uronosyl residues of the substrates. The rate of the reaction was highest for dermatan. Incubation of the products with chondroitinase ABC released essentially all the tritium. Dermatan sulfate and chondroitin sulfate were inactive as substrates, which indicates that epimerization takes place before sulfation. Analyses of the product obtained after incubation of chondroitin in 3H2O-containing medium for different incubation times showed that tritium accumulated first in L-iduronosyl residues. Later, tritium was also found in D-glucuronosyl residues. The reverse situation was observed when dermatan was used as substrate. After extended incubation times, the ratio of D-[3H]glucuronic acid to L-[3H]iduronic acid in both dermatan and chondroitin reached a value of 85/15, which may reflect the equilibrium value. Digestion of labeled chondroitin with chondroitinase AC and oxidation of labeled dermatan with periodate showed that after 96 h of incubation with the epimerase and 3H2O, most of the uronic acid residues had been involved in the reaction. Both products were composed of long blocks of D-glucuronic acid-containing disaccharides interrupted by a few L-iduronic acid-containing disaccharides arranged singly of in clusters of two to three. Reincubation of the 3H-labeled products originating from dermatan or chondroitin with the epimerase resulted in release of tritium, which was linear with time and with increasing protein concentration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6706927

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Organization of glycosaminoglycan sulfation in the biosynthesis of proteochondroitin sulfate and proteodermatan sulfate.

Authors:  J E Silbert
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

Review 2.  Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests.

Authors:  Florin Sasarman; Catalina Maftei; Philippe M Campeau; Catherine Brunel-Guitton; Grant A Mitchell; Pierre Allard
Journal:  J Inherit Metab Dis       Date:  2015-12-21       Impact factor: 4.982

3.  Ehlers Danlos Syndrome with Glycosaminoglycan Abnormalities.

Authors:  Noriko Miyake; Tomoki Kosho; Naomichi Matsumoto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

5.  Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate.

Authors:  Benny Pacheco; Anders Malmström; Marco Maccarana
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

6.  A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms.

Authors:  May Joy C Miller; Catherine E Costello; Anders Malmström; Joseph Zaia
Journal:  Glycobiology       Date:  2006-02-17       Impact factor: 4.313

7.  Sequence analysis of p-hydroxyphenyl-O-beta-D-xyloside initiated and radio-iodinated dermatan sulfate from skin fibroblasts.

Authors:  L A Fransson; B Havsmark; K Sakurai; S Suzuki
Journal:  Glycoconj J       Date:  1992-02       Impact factor: 2.916

8.  Oligosaccharide mapping of proteoglycan-bound and xyloside-initiated dermatan sulfate from fibroblasts.

Authors:  L A Fransson; A Schmidtchen; L Cöster; A Malmström
Journal:  Glycoconj J       Date:  1991-04       Impact factor: 2.916

Review 9.  Human genetic disorders and knockout mice deficient in glycosaminoglycan.

Authors:  Shuji Mizumoto; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

Review 10.  Biological functions of iduronic acid in chondroitin/dermatan sulfate.

Authors:  Martin A Thelin; Barbara Bartolini; Jakob Axelsson; Renata Gustafsson; Emil Tykesson; Edgar Pera; Åke Oldberg; Marco Maccarana; Anders Malmstrom
Journal:  FEBS J       Date:  2013-03-28       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.